Search research articles
Contact Us
Filters
Showing results (161-170 of 224) with videos related to
Page
of 23
Sort By:
JAMA Cardiology
|
November 13, 2021
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content
Nicholas A Marston, Robert P Giugliano, Giorgio E M Melloni, et al.
Journal of the American College of Cardiology
|
March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Lars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Circulation
|
November 12, 2019
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
Nicholas A Marston, Frederick K Kamanu, Francesco Nordio, et al.
Stroke
|
June 21, 2014
Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48
Robert P Giugliano, Christian T Ruff, Natalia S Rost, et al.
American Heart Journal
|
June 23, 2026
DOAC Score Among Patients Receiving Vitamin K Antagonists
Rahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
European Heart Journal
|
April 30, 2026
Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AF
Tze-Fan Chao, Eugene Braunwald, Michael G Palazzolo, et al.
Nature Medicine
|
February 26, 2025
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering
Nicholas A Marston, Frederick K Kamanu, Giorgio E M Melloni, et al.
Circulation
|
April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Nicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
Blood
|
May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71
Andre Maurice Small, Siddharth M Patel, Robert P Giugliano, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2026
Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 224) with videos related to
Sort By:
Page
of 23
JAMA Cardiology
|
November 13, 2021
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content
Nicholas A Marston, Robert P Giugliano, Giorgio E M Melloni, et al.
Journal of the American College of Cardiology
|
March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Lars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Circulation
|
November 12, 2019
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
Nicholas A Marston, Frederick K Kamanu, Francesco Nordio, et al.
Stroke
|
June 21, 2014
Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48
Robert P Giugliano, Christian T Ruff, Natalia S Rost, et al.
American Heart Journal
|
June 23, 2026
DOAC Score Among Patients Receiving Vitamin K Antagonists
Rahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
European Heart Journal
|
April 30, 2026
Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AF
Tze-Fan Chao, Eugene Braunwald, Michael G Palazzolo, et al.
Nature Medicine
|
February 26, 2025
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering
Nicholas A Marston, Frederick K Kamanu, Giorgio E M Melloni, et al.
Circulation
|
April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Nicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
Blood
|
May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71
Andre Maurice Small, Siddharth M Patel, Robert P Giugliano, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2026
Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
Page
of 23